top of page

ACTILYSE TREATMENT-SET 50 mg/vial

Product details

Registration number: SIN02340P

Classification: Prescription Only

Active ingredients: RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR

Strength: 50 mg/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.

ATC code: B01AD02

HSA approval date: 3 October 1988

Manufacturer(s): BOEHRINGER INGELHEIM PHARMA GMBH & CO KG

Manufacturing country/countries: GERMANY

What are the HSA registration number and classification for ACTILYSE TREATMENT-SET 50 mg/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN02340P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ACTILYSE TREATMENT-SET 50 mg/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR

Strength: 50 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ACTILYSE TREATMENT-SET 50 mg/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for ACTILYSE TREATMENT-SET 50 mg/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ACTILYSE TREATMENT-SET 50 mg/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): BOEHRINGER INGELHEIM PHARMA GMBH & CO KG

Manufacturing country/countries: GERMANY

Source for this answer

Where can I look up ACTILYSE TREATMENT-SET 50 mg/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN02340P or the exact product name ACTILYSE TREATMENT-SET 50 mg/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ACTILYSE TREATMENT-SET 50 mg/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ACTILYSE TREATMENT-SET 50 mg/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN02340P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page